Product Wiki · Recalls · Health Canada Consumer Product Safety

Recall 24406 — Archived - New Safety Information on the Use of DEPO-PROVERA (medroxyprogesterone acetate suspension for injection, 150 mgIM) associated with Bone Mineral Density Changes -Pfizer Canada Inc.

Health Canada Consumer Product Safety · Canada · 2005-06-30

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
Health Canada Consumer Product Safety
Recall identifier
24406
Date of alert
2005-06-30
Country / jurisdiction
Canada
Risk type
recall
Product category
Drugs
Product type
Marketed health products
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/archived-new-safety-informatio

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.